Pilot Company is a premier supplier of fuel, food, and travel essentials across North America, driven by its mission to fuel life's journeys. With over 800 retail locations, the company is dedicated to providing exceptional customer service, quality products and convenience. Pilot Company's commitment to its team members is reflected in its comprehensive benefits program and partnership with CuraLinc, prioritizing their wellbeing and ensuring they are fueled for the journey ahead.
CuraLinc measured the health and productivity of Pilot team members who used the EAP in 2022. During the initial clinical assessment for each new EAP user, CuraLinc’s Care Advocates, all of whom are licensed mental health counselors, offered the SPS-6 and WOS to all team members; and offered the PHQ-9 and AUDIT to those who presented with depression and alcohol use, respectively. CuraLinc followed up with participants 30 days after the case was closed to measure changes in their health and productivity, evaluate their satisfaction with the program and profile for variations in health status or referrals to other resources.
90% of team members with depression showed improvement after using the program
|
81% of team members reported improved productivity
|
Team members who used the program missed 8.5 hours less work time
|
100% of team members who presented with alcohol use or abuse reported reduced risk
|
97% of team members reported satisfaction with the program
|
90% of team members with depression showed improvement after using the program | 81% of team members reported improved productivity | Team members who used the program missed 8.5 hours less work time | 100% of team members who presented with alcohol use or abuse reported reduced risk | 97% of team members reported satisfaction with the program |
CuraLinc uses clinically validated tools to measure the impact of the EAP, including the PHQ-9 for depression, the SPS-6 for productivity, the WOS for absenteeism and the AUDIT for alcohol abuse. These tools allow CuraLinc to establish quantifiable baselines and measure post-treatment outcomes from program participants — supporting the value of CuraLinc’s approach to providing evidence-based care through multiple modalities.
For Pilot, the partnership with CuraLinc led to lower rates of depression, higher productivity, reduced absenteeism and less risk of alcohol abuse — detailed in a case study titled, ‘EAP Outcomes and Impact.’
Want to learn more about CuraLinc and supports the emotional fitness of Pilot’s team members? Complete the form below to access the study.
.